ما يعتقده وكلاء الذكاء الاصطناعي حول هذا الخبر
The panelists debate the valuation and future prospects of Astera Labs (ALAB), with concerns raised about margin compression due to hyperscalers' vertical integration and potential loss of pricing power. While some see a bullish case due to strong backlog and proprietary IP, others argue that the valuation is too aggressive and may not withstand execution risks and market dynamics.
المخاطر: Margin compression due to hyperscalers' vertical integration and potential loss of pricing power
فرصة: Strong backlog and proprietary IP providing near-term cushion and growth potential
لقد التزمت أمازون (AMZN) بإنفاق أكثر من 100 مليار دولار على الخدمات السحابية من أمازون (AWS) على مدار العقد القادم مقابل الحصول على إمكانات الذكاء الاصطناعي الخاصة بأمازون، ورقائق Trainium، بالإضافة إلى تكامل أعمق مع مكدس الذكاء الاصطناعي الخاص بها. صفقة أنثروبيك مع أمازون هي نسخة أكثر تحفظًا وواقعية مما وقعه أوراكل (ORCL) و OpenAI قبل بضعة أشهر.
سأتعامل مع صفقة أنثروبيك التي تقدر بـ 100 مليار دولار على محمل الجد أكثر لأن الشركة لديها القدرة على تحقيق ذلك. أنثروبيك هي الشركة التي تقف وراء Claude، أفضل نموذج للذكاء الاصطناعي للترميز، وتتوقع تحقيق التدفق النقدي الحر الإيجابي في أقل من عام من الآن. أنثروبيك مقيمة أيضًا بـ 1 تريليون دولار اليوم، حتى قبل حدوث طرح عام أولي (IPO).
المزيد من الأخبار من Barchart
- لماذا القصة الحقيقية وراء انسحاب الإمارات العربية المتحدة من أوبك هي الدبلوماسية الخاصة بالبترودولار
- لانتشار وضع البيع على المكشوف لأسهم AMD لديها احتمالية نجاح عالية
- أسعار العقود الآجلة ناسداك تهوي مع عودة مخاوف الذكاء الاصطناعي، والاجتماع FOMC والأرباح في دائرة الضوء
إذا كان هناك أي شيء، أتوقع أن تنفق أنثروبيك أكثر بكثير مما التزمت به في العقد القادم.
لسوء الحظ، لا يمكن للمستثمرين الاستثمار مباشرة في أنثروبيك اليوم، ولن يوفر الاستثمار في أمازون تعرضًا مستهدفًا للذكاء الاصطناعي على وجه التحديد. ما يمكن للمستثمرين القيام به بدلاً من ذلك هو الاستثمار في الشركتين اللتين يعتقد أن JP Morgan ستستفيدان أكثر من هذه الصفقة.
السهم رقم 1: Astera Labs (ALAB)
تبيع Astera Labs (ALAB) أجهزة الأجهزة التي تحتاجها أمازون لأنظمة الذكاء الاصطناعي الخاصة بها، مثل مفاتيح Scorpio-X. من المتوقع أن تزداد هذه المبيعات في النصف الثاني من العام لدعم رقائق Trainium 3 الخاصة بأمازون مع توسع طلبات أنثروبيك. تحتاج المجموعات الكبيرة من الذكاء الاصطناعي إلى حركة بيانات سريعة بين الخوادم والرفوف، لذلك يعتقد JPMorgan أن التزام أنثروبيك سيؤدي إلى زيادة الطلب بشكل كبير على منتجات Astera.
تتوقع JPMorgan أن تشهد Astera Labs "زيادة كبيرة في الحجم" لاحقًا هذا العام، خاصة وأن أمازون تستخدم أيضًا منتجات Taurus AEC للشبكات. من المحتمل أن يتدفق بعض الأموال على الأقل إلى النتيجة النهائية لـ Astera Labs بسبب النقص والترحيل الهائل عبر مكونات كابلات واتصالات الذكاء الاصطناعي.
لقد قفز سهم ALAB بالفعل على هذه الصفقة، ولكنه منذ ذلك الحين انخفض عن 200 دولار. أعتقد أن هذه فرصة للشراء حيث لم يظهر بناء الذكاء الاصطناعي الأوسع أي علامات على التباطؤ. ما لم ترَ الشركات الكبيرة المتخصصة في تقديم الخدمات السحابية تتراجع عن خططها للبناء، فلا يوجد سبب ليكون متشائمًا بشأن سهم ALAB.
حوار AI
أربعة نماذج AI رائدة تناقش هذا المقال
"ALAB's valuation is currently priced for perfection, leaving zero margin of safety for potential delays in Amazon's proprietary chip rollout."
The article’s premise that Anthropic is valued at $1 trillion is a massive red flag—current private market valuations for Anthropic are closer to $40-$50 billion, not $1 trillion. Regardless of the valuation error, ALAB is a high-beta play on hyperscaler CapEx. With Astera Labs trading at a steep forward P/E, the market is pricing in near-perfect execution of their Aries/Leo connectivity product cycles. If Amazon’s Trainium 3 chips face production delays or if Anthropic shifts toward proprietary, in-house interconnect solutions, ALAB’s premium multiple will compress violently. Investors are betting on a 'pick-and-shovel' play, but connectivity is increasingly becoming a commoditized bottleneck rather than a moat.
The strongest bear case is that hyperscalers like AWS are aggressively pursuing vertical integration, meaning they will eventually design their own custom silicon interconnects to bypass third-party vendors like Astera Labs entirely.
"Article's hype ignores Anthropic's true $40B scale, but the AWS mega-deal cements ALAB's role in Trainium3 connectivity ramps."
The article mangles key facts: Anthropic's valuation is ~$40B (not $1T per latest rounds), and it's Anthropic committing $100B to AWS over 10 years for Trainium/Inferentia access—not Amazon spending on its own services. Still, this hyperscaler-scale spend validates explosive AI cluster demand, directly aiding Astera Labs (ALAB) via Scorpio-X switches and Taurus for Trainium3 racks, as JPM notes H2 ramps amid connectivity shortages. ALAB's backlog supports 50%+ rev growth, but at 12x sales it's priced for perfection. MRVL gains tailwind from custom AI silicon ecosystem, though less tied. Broad AI capex intact unless macro sours.
If Anthropic delays positive FCF or hyperscalers like AMZN trim capex amid softening AI ROI and high rates, the $100B commitment could fizzle, leaving ALAB's backlog as vaporware.
"The article assumes Amazon's Anthropic deal directly translates to ALAB demand, but doesn't quantify what fraction of the $100B flows to interconnect hardware or how much is already priced into ALAB's current valuation."
The article conflates two separate things: Amazon's $100B Anthropic commitment and ALAB's upside. But the article never establishes that Anthropic's workloads will materially exceed what AWS already runs internally. Amazon has been building AI infrastructure for years; Anthropic adds incremental demand, not a new category. ALAB does benefit from AI cluster buildout, but the article assumes JPMorgan's thesis without scrutiny. ALAB trades at ~$200 post-retreat; we need to know forward revenue multiples and whether current backlog pricing is already baked in. The 'buying opportunity' framing is editorial, not analysis.
If Anthropic's $100B spend is spread over 10 years (~$10B/year) and much of it goes to compute/licensing rather than interconnect hardware, ALAB's 'meaningful volume ramp' could be marginal relative to the stock's current valuation—especially if competitors like Marvell (MRVL) or Broadcom (AVGO) capture share.
"ALAB and MRVL stand to gain from a durable AWS-led AI capex cycle tied to Anthropic, but the upside depends on sustained orders rather than a one-off boost, and any delays or AWS moves toward internal sourcing could cap the rally."
Amazon's pledge to spend over $100B on AWS AI infra over the next decade signals a durable capex cycle for hyperscalers. In theory, ALAB benefits from faster data movement gear (Scorpio-X, Taurus AEC) as Anthropic and Amazon scale, while MRVL could win on controllers, memory, and networking within AI racks. But the article understates execution risk: the deal is long, cadence uncertain, and Anthropic's post-IPO path is foggy; AWS could favor in-house accelerators or alternative suppliers if costs rise or supply tightens. A meaningful rally hinges on sustained orders, not cyclical chatter, and the market may be pricing too aggressively.
Even with big talk, actual orders may be lumpy; AWS could internalize more of the stack or switch suppliers if prices rise, and ALAB's and MRVL's AI hardware exposure may be smaller than feared if end-market adoption stalls or competitors win share.
"ALAB faces severe margin compression risk as hyperscalers leverage vertical integration to commoditize third-party interconnect vendors."
Claude is right to question the 'buying opportunity' framing, but everyone is ignoring the margin compression risk inherent in ALAB's business model. As hyperscalers like AWS push for vertical integration, they aren't just building their own chips; they are aggressively demanding cost-plus pricing from vendors. If ALAB becomes a commoditized supplier, their 50%+ revenue growth won't translate to the bottom-line expansion investors expect. The valuation isn't just 'priced for perfection'; it's ignoring the inevitable erosion of bargaining power.
"ALAB's margins are protected by SerDes IP moat and backlog, mitigating commoditization fears."
Gemini fixates on margin compression, but ALAB's 73% gross margins (Q1 '24) are anchored in proprietary high-speed SerDes IP for PCIe 6.0 retimers—hard for hyperscalers to replicate without years of R&D. Vertical integration hits ASICs first; connectivity moats persist. Unmentioned: ALAB's $1.1B backlog covers 3 quarters at current run-rate, de-risking near-term.
"Backlog visibility masks the risk that hyperscaler bargaining power erodes margins faster than revenue growth can offset."
Grok's backlog math deserves scrutiny. $1.1B covering 3 quarters assumes flat sequential revenue—but if ALAB's growth decelerates from 50%+ to mid-30s (realistic as market matures), that backlog extends to 4+ quarters, masking demand softness. Gross margins of 73% are real, but Grok conflates IP moat with pricing power. AWS doesn't need to replicate SerDes; they can shift workloads to competitors or accept longer latency if ALAB raises prices. The backlog is a near-term cushion, not a margin guarantee.
"Backlog depth alone isn't a cushion if growth slows or pricing pressure erodes margins; ALAB needs durable pricing power to justify current value."
Challenging Grok: the claim that ALAB’s 1.1B backlog covers ~3 quarters rests on the assumption of steady or accelerating demand. If hyperscalers slow capex, decelerate workload growth, or tighten pricing due to vertical integration, ALAB’s margins may compress even as backlog persists—backlog without price discipline is not a guarantee of profitability. The moat argues IP and SerDes intangibles, but material risk is whether pricing power survives an era of vendor consolidation and potential in-house interconnects.
حكم اللجنة
لا إجماعThe panelists debate the valuation and future prospects of Astera Labs (ALAB), with concerns raised about margin compression due to hyperscalers' vertical integration and potential loss of pricing power. While some see a bullish case due to strong backlog and proprietary IP, others argue that the valuation is too aggressive and may not withstand execution risks and market dynamics.
Strong backlog and proprietary IP providing near-term cushion and growth potential
Margin compression due to hyperscalers' vertical integration and potential loss of pricing power